The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment

Clinical trial NCT01655823 · TERMINATED

Trial details

NCT number: NCT01655823
Sponsor: Wex Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain Peripheral Neuropathy Neuropathic Pain

Start date: 2012-07-01
Primary completion: 2015-01-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.